FLSM
MTEM

Frazier Life Sciences Management’s Molecular Templates, Inc. MTEM Stock Holding History

Frazier Life Sciences Management’s Portfolio MTEM Stock Details MTEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-91,603
Closed -$1.03M – 48
2022
Q3 		$1.03M Hold
91,603
– – 0.08% 41
2022
Q2 		$1.25M Hold
91,603
– – 0.12% 38
2022
Q1 		$4.74M Buy
+91,603
New +$4.05M 0.4% 35

Other funds holding MTEM

BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Frazier Life Sciences Management's MTEM Position: Q4 2022 in Review

Frazier Life Sciences Management sold out of Molecular Templates, Inc. (MTEM) in Q4 2022, closing a stake of 91,603 shares — an estimated $1.03M sold.

Frazier Life Sciences Management first reported a position in MTEM in Q1 2022 and held it in 3 quarters. The position peaked at $4.74M in Q1 2022. 49 funds tracked by Wall St. Rank hold MTEM as of Q4 2022.

  • Frazier Life Sciences Management reported no remaining Molecular Templates, Inc. position as of Q4 2022 after selling out during the quarter.
  • Frazier Life Sciences Management sold 91,603 Molecular Templates, Inc. shares in Q4 2022, an estimated $1.03M.
  • Frazier Life Sciences Management first reported a position in Molecular Templates, Inc. in Q1 2022 and held it in 3 quarters.
  • Frazier Life Sciences Management's Molecular Templates, Inc. position peaked at $4.74M in Q1 2022.
  • 49 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q4 2022.

Based on Frazier Life Sciences Management's 13F filing for Q4 2022, filed 3 Feb 2023.